Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Molly Harper currently holds 3,694 shares of CATALYST PHARMACEUTICALS, INC. (CPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Molly Harper has been a net seller of CPRX stock. They have purchased $0 and sold $910.3K worth of shares.
Molly Harper's most recent insider trade was on Dec 29, 2025, when they sold 1,334 shares at $0.00 per share.
Molly Harper serves as Executive at CATALYST PHARMACEUTICALS, INC. (CPRX). They have executed 20 insider transactions totaling $910.3K over their tenure at the company.
Molly Harper holds the position of Executive at CATALYST PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Molly Harper has shown a selling trading pattern, with $0 in total purchases and $910.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Molly Harper was on Dec 12, 2025, when they sold $360.2K worth of CPRX shares. This transaction involved 15,527 shares at $23.20 per share.
Molly Harper currently owns 3,694 shares of CATALYST PHARMACEUTICALS, INC. (CPRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Molly Harper's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Molly Harper has 20 Form 4 filings on record as an insider at CATALYST PHARMACEUTICALS, INC..
Set alerts for Molly Harper and 40,000+ other insiders.